17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
Many U.S. employers have recently experienced frustration over legal obstacles to keeping high quali...
Read More >
I used to use a lot of paper in my law practice. Then I had 10 feet of water in my office after Hurr...
Read More >
Last week Congress and the President actually got together on something and passed a huge appropriat...
Read More >
California Governor Gavin Newsom has signed numerous pro-employee bills into law that will impact al...
Read More >
In recent years, the autism services market has been robust. At the recent Annual Healthcare and Lif...
Read More >
Investors and their stakeholders are increasing the use of environmental, social and governance (ESG...
Read More >